Avicanna IncOTCQX International:AVCNFView on Canadian Exchange
- LAST PRICE0.1857
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots0.1432/ 50
- Ask / Lots0.2233/ 25
- Open / Previous Close--- / 0.1857
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | AVCNF |
|---|---|---|
| 12:19 ET | 1200 | 0.1857 |
Nov 14, 2024
Avicanna Reports Q3 2024, from 5:18PM ET on Thursday Nov 14, 2024 by Dow Jones
5:18PM ET on Thursday Nov 14, 2024 by Dow Jones*DJ Avicanna 3Q Rev C$6.3M >AVCN.T, from 5:18PM ET on Thursday Nov 14, 2024 by Dow Jones
5:18PM ET on Thursday Nov 14, 2024 by Dow Jones
Nov 4, 2024
Avicanna Announces Closing of Non-Brokered Private Placement, from 5:30PM ET on Monday Nov 04, 2024 by Dow Jones
5:30PM ET on Monday Nov 04, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Avicanna Inc | 29.0M | --- | --- |
Company Information
Avicanna Inc. is a Canada-based commercial-stage international biopharmaceutical company. The Company's scientific platform commercializes over thirty products across various market segments: Medical Cannabis formulary (RHO Phyto), Medical cannabis care platform (MyMedi.ca), Pharmaceutical pipeline, and Active pharmaceutical ingredients (Aureus Santa Marta). RHO Phyto formulary offers a diverse range of proprietary products, including oral, sublingual, topical, and transdermal deliveries with varying ratios of cannabinoids. MyMedi.ca is a medical cannabis care platform and features a diverse portfolio of products and bilingual pharmacist-led patient support programs. Aureus Santa Mart is a commercial-stage business providing a various forms CBD, THC and CBG to the Company's international partners for use in the development and production of food, cosmetics, medical, and pharmaceutical products.
Contact Information
- Headquarters
- 480 UNIVERSITY AVENUE, SUITE 1502TORONTO, ON, Canada M5G 1V2
- Phone
- 647-243-5283
- Fax
- 647-243-5283
Executives
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $29.0M |
|---|---|
Revenue (TTM) | $24.9M |
Shares Outstanding | 109.6M |
Avicanna Inc does not pay a dividend. | |
Beta | 1.49 |
EPS | $-0.07 |
Book Value | $0.00 |
P/E Ratio | --- |
Price/Sales (TTM) | 1.2 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -25.19% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
